8-K: Kiora Pharmaceuticals Reports Second Quarter Results; Retinal Disease Drug Development Pipeline Advancing Toward Two Phase 2 Studies
8-K: Current report
8-K: Current report
8-K: Current report
8-K: Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
KIORA PHARMACEUTICALS INC | DEF 14A: Definitive information statements
KIORA PHARMACEUTICALS INC | 8-K: Current report
KIORA PHARMACEUTICALS INC | PRE 14A: Preliminary proxy statements relating to merger or acquisition
KIORA PHARMACEUTICALS INC | S-3: Registration statement for specified transactions by certain issuers
KIORA PHARMACEUTICALS INC | 8-K: Current report
KIORA PHARMACEUTICALS INC | 8-K: Current report
KIORA PHARMACEUTICALS INC | 8-K: Current report
KIORA PHARMACEUTICALS INC | 8-K: Current report